Article info

Download PDFPDF

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Authors

  1. Correspondence to Dr Kumar Prabhash; kumarprabhashtmh{at}gmail.com
View Full Text

Citation

Patil VM, Noronha V, Joshi A, et al
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Publication history

  • Received January 25, 2017
  • Revised January 30, 2017
  • Accepted January 31, 2017
  • First published April 27, 2017.
Online issue publication 
April 27, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.